DHI

DR Horton
D

DHI

Arincen52/100B

DR Horton operating income 1992–2026

DR Horton's operating income in Q4 FY2026, the three months to 30 September 2026, was 1.01B USD, down 9.9% on the same quarter a year before. DR Horton's operating income over the last twelve months was 3.61B USD, down 18.4% on the twelve months before. In fiscal year 2026 it was 3.61B USD, down 18.4% on the year before.

Last updated 6 Nov 2026 · Next report 19 Jan 2027

Operating income

Operating income · +10.1% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 20263.61B-18.36%10.93%7.36B22.28%4.02B
FY202630 Sept 20263.61B-18.36%10.93%7.36B22.28%4.02B
FY202530 Sept 20254.42B-27.64%12.92%8.12B23.70%4.84B
FY202430 Sept 20246.11B-2.04%16.61%9.54B25.91%6.37B
FY202330 Sept 20236.24B-19.03%17.60%9.35B26.37%6.41B
FY202230 Sept 20227.71B+42.98%23.02%10.50B31.37%7.71B
FY202130 Sept 20215.39B+82.47%19.41%7.88B28.35%5.43B
FY202030 Sept 20202.95B+43.79%14.55%4.94B24.31%3.06B
FY201930 Sept 20192.05B+0.71%11.68%3.87B22.01%2.20B
FY201830 Sept 20182.04B+22.59%12.70%3.67B22.84%2.12B
FY201730 Sept 20171.66B+20.25%11.81%3.05B21.63%1.66B
FY201630 Sept 20161.38B+20.81%11.38%2.65B21.84%1.41B
FY201530 Sept 20151.15B+41.48%10.58%2.29B21.14%1.18B
FY201430 Sept 2014809.80M+26.63%10.09%1.76B21.89%852.60M
FY201330 Sept 2013639.50M+158.49%10.22%1.41B22.46%685.60M
FY201230 Sept 2012247.40M+332.52%5.68%861.60M19.79%288.60M
FY201130 Sept 201157.20M-67.01%1.57%613.50M16.87%83.90M
FY201030 Sept 2010173.40M—3.94%772.60M17.56%204.90M
FY200930 Sept 2009-482.20M—-13.18%118.90M3.25%-429.40M
FY200830 Sept 2008-2.53B—-38.03%-1.64B-24.61%-2.54B
FY200730 Sept 2007-483.90M-124.51%-4.28%811.40M7.18%-863.20M
FY200630 Sept 20061.97B-15.96%13.12%3.63B24.14%2.10B
FY200530 Sept 20052.35B+50.25%16.94%3.72B26.86%2.45B
FY200430 Sept 20041.56B+55.27%14.42%2.64B24.38%1.63B
FY200330 Sept 20031.01B+52.60%11.54%1.92B22.02%1.05B
FY200230 Sept 2002659.86M+46.97%9.79%1.37B20.40%700.51M
FY200130 Sept 2001448.97M+41.76%10.08%928.37M20.84%485.03M
FY200030 Sept 2000316.71M+15.84%8.67%737.08M20.17%341.20M
FY199930 Sept 1999273.40M+52.14%8.66%616.30M19.53%294.21M
FY199830 Sept 1998179.70M+57.49%8.25%421.10M19.34%189.54M
FY199730 Sept 1997114.10M+20.61%13.63%156.40M18.68%121.80M
FY199630 Sept 199694.60M+184.94%17.28%100.80M18.42%100.40M
FY199530 Sept 199533.20M+18.15%7.59%79.70M18.22%35.20M
FY199430 Sept 199428.10M+105.11%7.14%68.40M17.39%29.30M
FY199330 Sept 199313.70M+26.85%7.21%34.90M18.36%14.10M
FY199230 Sept 199210.80M—8.70%24.10M19.42%14.50M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about DR Horton's operating income

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.